These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32229549)

  • 1. Management of difficult-to-treat
    Sullivan MH; Boggiano VL; Smith KL
    BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32229549
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mullish BH; Williams HR
    Clin Med (Lond); 2018 Jun; 18(3):237-241. PubMed ID: 29858434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
    Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF
    Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile Colitis.
    Pumiglia L; Wilson L; Rashidi L
    Surg Clin North Am; 2024 Jun; 104(3):545-556. PubMed ID: 38677819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.
    Cymbal M; Chatterjee A; Baggott B; Auron M
    Am J Med; 2024 Jul; 137(7):571-576. PubMed ID: 38508330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Updated Czech guidelines for the treatment of patients with colitis due to Clostridioides difficile].
    Beneš J; Stebel R; Musil V; Krůtová M; Vejmelka J; Kohout P
    Klin Mikrobiol Infekc Lek; 2022 Sep; 28(3):77-94. PubMed ID: 36791303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
    Yakout A; Bi Y; Harris DM
    J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
    Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
    Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: The epidemiology and management of Clostridioides difficile infection-A clinical update.
    Clarke LM; Allegretti JR
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1335-1349. PubMed ID: 38534216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.
    Konturek PC; Haziri D; Helfritzsch H; Hess T; Harsch IA
    Med Princ Pract; 2017; 26(2):182-184. PubMed ID: 27978522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. My Treatment Approach to Clostridioides difficile Infection.
    Khanna S
    Mayo Clin Proc; 2021 Aug; 96(8):2192-2204. PubMed ID: 34175104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances related to Clostridium difficile infection.
    Kim YG; Jang BI
    Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
    Yamaguchi T; Konishi H; Aoki K; Ishii Y; Chono K; Tateda K
    J Infect Chemother; 2020 May; 26(5):483-491. PubMed ID: 32165071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
    Okumura H; Fukushima A; Taieb V; Shoji S; English M
    J Infect Chemother; 2020 Jan; 26(1):43-50. PubMed ID: 31624029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to: Clostridioides difficile infection in children.
    Krutova M; de Meij TGJ; Fitzpatrick F; Drew RJ; Wilcox MH; Kuijper EJ
    Clin Microbiol Infect; 2022 Aug; 28(8):1085-1090. PubMed ID: 35283312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.